Institutional Perspectives in Cancer: Ovarian Cancer - Chaired by Ursula Matulonis, MD and Joyce Liu, MD, MPH

Video

In Partnership With:

Institutional Perspectives in Cancer: Ovarian Cancer - Chaired by Ursula Matulonis, MD and Joyce Liu, MD, MPH

Institutional Perspectives in Cancer: Ovarian Cancer - Chaired by Ursula Matulonis, MD and Joyce Liu, MD, MPH

The live filming of this virtual event in our IPC series is now on-demand.

OncLive is proud to present the State of the Science Summits and a new virtual event, Institutional Perspectives in Cancer (IPC). Each summit and webinar will convene for a short meeting designed to educate healthcare professionals on the clinical benefits associated with new science driving new thinking in cancer management. Attendees will not only improve their knowledge of novel treatment approaches, but also leave the event the with confidence and intent to apply state-of-the-art treatment strategies to care for their patients. Each event is dedicated to the latest research in one of the following therapeutic areas: Breast Cancer, Lung Cancer, GU & Prostate Cancer, Hematology, or Melanoma.

The State of the Science Summits and IPC assemble academic and community-based physicians & healthcare professionals across key disciplines from medical and surgical oncology. Specialist experts serve as faculty for these premier and renowned oncology summits, which focus on the most relevant cancer topics to ultimately improve patient care.

Speakers 

  • Ursula Matulonis, MD | Dana-Farber Cancer Institute
  • Joyce Liu, MD, MPH | Dana-Farber Cancer Institute
  • Rebecca Porter, MD, PhD | Dana-Farber Cancer Institute
  • Elizabeth Lee, MD | Dana Farber Cancer Institute

Topics

  • How Have PARPS Changed The Treatment Landscape for Ovarian Cancer?
  • ADCS in Platinum-Resistant Ovarian Cancer
  • Emerging IO Therapies in Ovarian Cancer
  • New Targeted Therapy Approaches in Ovarian Cancer

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD
Erin K. Crane, MD, MPH
Núria Agustí Garcia, MD
Gabriella Smith, MD
Shannon N. Westin, MD, MPH, FACOG, director, Early Drug Development, clinical medical director, professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, codirector, Ovarian Cancer Moonshot Program, The University of Texas MD Anderson Cancer Center
Haeseong Park, MD, MPH
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Debra L. Richardson, MD, FACS, FACOG
Jennifer Brown, MD, PhD
Premal Thaker, MD, MS